The Zoonotic Disease Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the zoonotic disease treatment has significantly expanded in the past few years, proliferating from $39.71 billion in 2024 to $42.64 billion in 2025. This indicates a compound annual growth rate (CAGR) of 7.4%.
The zoonotic disease treatment market is projected to reach $55.92 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.0%.
Download Your Free Sample of the 2025 Zoonotic Disease Treatment Market Report and Uncover Key Trends Now!The drivers in the zoonotic disease treatment market are:
• Emergence of major zoonotic outbreaks
• Urbanization and habitat encroachment
• The implementation of the one health approach
• Increased surveillance, reporting, public education and awareness on zoonotic diseases.
The zoonotic disease treatment market covered in this report is segmented –
1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
The trends in the zoonotic disease treatment market are:
• The development of broad-spectrum antivirals is an emerging trend.
• Strengthening global health infrastructure is becoming increasingly prominent.
• There are advancements in diagnostic technology transforming the market.
• There is a growing focus on preventive measures and vaccine development platforms.
The major players in the zoonotic disease treatment market are:
• Pfizer Inc.
North America was the largest region in the zoonotic disease treatment market in 2023